Animal Pharm is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Antiparasitics

Set Alert for Antiparasitics

Merck gains Estrumate US supplemental approval

The US FDA has handed a supplemental approval to Merck Animal Health for its Estrumate (cloprostenol injection) reproductive injectable for cows.

Merck MSD Animal Health Zoetis

MSD adds to Bravecto, Porcilis and Bovilis ranges with European approvals

European authorities have approved MSD Animal Health's Bravecto Plus (fluralaner/moxidectin) for the treatment of ear mites in cats.

Merck MSD Animal Health Product Approvals

Boehringer's Nexgard, Broadline get European variation boost

European authorities have paved the way for an extension to Boehringer Ingelheim Animal Health's top-selling NexGard antiparasitic brand. 

Boehringer Ingelheim Animal Health Product Approvals

Zoetis takes major step ahead in triple combo antiparasitic race with EU positive opinion

Zoetis has gained a significant boost in the run-up to introducing a new three-way antiparasitic blockbuster product after receiving the green light from European authorities.

Zoetis Canine

Zoetis 12-month heartworm antiparasitic approved for dogs in US

The US FDA has approved Zoetis' ProHeart 12 injectable heartworm prevention for dogs.

United States Zoetis

Bayer gains positive opinion for feline additions to Advocate Spot-on

Bayer Animal Health's Advocate Spot-on has received a positive opinion for new indications in cats in the EU.

Europe Antiparasitics

After the isoxazoline gold rush: Where will industry turn for next big antiparasitic windfall?

The antiparasitic space has been an active battleground for the animal health industry for many decades. It is the largest single product market in animal health and will undoubtedly remain a key growth driver over the coming years. Animal Pharm editor Joseph Harvey canvassed opinion from a range of thought leaders on opportunities and challenges in this key blockbuster market. 

Antiparasitics Companion Animals

Virbac gains European positive opinion for new antiparasitic generic

European authorities have paved the way for Virbac to gain authorization of Evicto – a generic antiparasitic for cats and dogs.

Virbac Antiparasitics

Bravecto Plus gets CVMP go ahead for variation approval

European authorities have recommended MSD Animal Health's Bravecto Plus (fluralaner/moxidectin) be approved for treating ear mites in cats. 

Product Approvals Policy & Regulation

Bayer introduces Advantage to China's burgeoning pet medicines market

Bayer Animal Health has further increased its pet portfolio in China by launching its top-selling product – Advantage – in the country.

Bayer Animal Health Antiparasitics

Zoetis leads Japanese approvals in 2018 and across 10-year scope

Zoetis received three approvals from the Japanese Ministry of Agriculture, Forestry and Fisheries (JMAFF) in 2018, bolstering its position as the firm with the most new products in Japan over the last 10 years.

 

Japan Markets

Zoetis, Chanelle bag pet parasiticide approvals in EU

Zoetis and Irish generics specialist Chanelle Pharmaceuticals have both recently gained authorizations from the European Medicines Agency (EMA) for companion animal antiparasitics.

EU Antiparasitics
See All
Advertisement
UsernamePublicRestriction

Register